N/A
Completed N=20
Radiofrequency Hyperthermia Safety Study
Postoperative Pain · Soft Tissue Injuries · Wound Heal · Blood Flow
Source: ClinicalTrials.gov NCT05399771 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: Mean Temperature Change- Skin Evaluation on Leg With Device — 6.21 degrees
Summary
This study will include 20 healthy subjects with intact skin on their lower legs that meet inclusion criteria. Participants will serve as their own control, by heating one leg and not the other. The radiofrequency device consists of a 4 by 6 inch heating pad connected to a temperature controller. Subjects will receive weekly treatments for 4 weeks, and will be re-evaluated 4 weeks after the last treatment to assess any tissue changes that continue after the treatments have concluded.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Temperature Change- Skin Evaluation on Leg With Device |
7.647 | — |
| PRIMARY Mean Change in Blood Perfusion Assessment - mL/kg/Min |
430.312 | — |
| PRIMARY Blood Perfusion Assessment - mL/kg/Min |
29.659 | — |
| PRIMARY Change in Comfort Level Scores of Participants Receiving Hyperthermia Treatment |
— | — |
| PRIMARY Safety: Number of Blister Formations |
— | — |
| PRIMARY Safety: Significant Changes in Redness |
— | — |
| SECONDARY Number of Participants Who Attended the Session |
16 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years or older
- Healthy
- 20<BMI<40
Exclusion Criteria
- Pregnant, nursing or child bearing potential
- Active infections of the skin in the lower leg
- Open or healing wounds on the lower leg
- Autoimmune disorder
- 40<BMI <20
- History of blood clots
- History of lower limb edema
- Tattoos and metal hardware in the leg
Data sourced from ClinicalTrials.gov (NCT05399771). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.